The minor gentamicin complex component, X2, is a potent premature stop codon readthrough molecule with therapeutic potential

Nonsense mutations, resulting in a premature stop codon in the open reading frame of mRNAs are responsible for thousands of inherited diseases. Readthrough of premature stop codons by small molecule drugs has emerged as a promising therapeutic approach to treat disorders resulting from premature ter...

詳細記述

保存先:
書誌詳細
出版年:PLoS One
主要な著者: Friesen, Westley J., Johnson, Briana, Sierra, Jairo, Zhuo, Jin, Vazirani, Priya, Xue, Xiaojiao, Tomizawa, Yuki, Baiazitov, Ramil, Morrill, Christie, Ren, Hongyu, Babu, Suresh, Moon, Young-Choon, Branstrom, Art, Mollin, Anna, Hedrick, Jean, Sheedy, Josephine, Elfring, Gary, Weetall, Marla, Colacino, Joseph M., Welch, Ellen M., Peltz, Stuart W.
フォーマット: Artigo
言語:Inglês
出版事項: Public Library of Science 2018
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6201930/
https://ncbi.nlm.nih.gov/pubmed/30359426
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0206158
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料